Liquidia (LQDA) Interest & Investment Income (2020 - 2026)
Liquidia (LQDA) recorded quarterly Interest & Investment Income of $1.8 million in Q1 2026, up 6.3% quarter-over-quarter from $1.7 million in Q4 2025, and up 2.55% on a YoY basis from $1.7 million in Q1 2025.
Liquidia (LQDA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Liquidia's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 2.55% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $6.7 million (down 11.12% YoY), while the FY2025 annual figure was $6.6 million, down 13.46% from the prior year.
- Interest & Investment Income was $1.8 million for Q1 2026 at Liquidia, up from $1.7 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.1 million in Q4 2024 to a low of $4000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.2 million across 5 years, with a median of $1.6 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income plunged 80.95% in 2022, then surged 22950.0% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $662000.0 in 2022, then soared by 43.2% to $948000.0 in 2023, then surged by 121.94% to $2.1 million in 2024, then decreased by 20.77% to $1.7 million in 2025, then increased by 6.3% to $1.8 million in 2026.
- The last three Interest & Investment Income figures came in at $1.8 million (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 948,000.00 |
| Sep 30, 2023 | 862,000.00 |
| Jun 30, 2023 | 734,000.00 |
| Mar 31, 2023 | 922,000.00 |
| Dec 31, 2022 | 662,000.00 |
| Sep 30, 2022 | 359,000.00 |
| Jun 30, 2022 | 65,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 5,000.00 |